Biotech News

Outset Medical Reports Third-Quarter Results

Outset Medical (OM)Outset MedicalEarnings

SAN JOSE, Calif. , Nov. 10, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the third quarter ended September 30, 2025 and revised

Related news

Outset Medical

Dialysis Technology Outset Medical develops technology intended to simplify dialysis delivery across hospitals, clinics and home-care settings. Tablo Hemodialysis System Tablo is an integrated hemodialysis system that combines water purification, on-demand dialysate production and treatment delivery in a single device. Its design seeks...

Recent company news

Stock data

Close
4.21 USD
Market cap
93.98M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States